One-plasmid double-expression system for preparation of MS2 virus-like particles packaging SARS-CoV-2 RNA

被引:0
|
作者
Qi, Lili [1 ]
Zhang, Zheng [1 ]
Wang, Mengting [1 ]
Ke, Zhijian [1 ]
Mao, Haiguang [1 ]
Deng, Gang [2 ]
Wang, Jinbo [1 ]
机构
[1] NingboTech Univ, Sch Biol & Chem Engn, Ningbo, Zhejiang, Peoples R China
[2] Ningbo Cent Blood Stn, Blood Transfus Res Inst, Ningbo, Zhejiang, Peoples R China
关键词
MS2 virus -like particles; SARS-CoV-2; RT-qPCR; COVID-19; MS2; VLPs; EXTERNAL QUALITY ASSESSMENT; MOLECULAR-DETECTION; ARMORED RNA; AGGREGATION; STABILITY; IMPACT;
D O I
10.3389/fcimb.2023.1238543
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
COVID-19 is a disease caused by a virus named SARS-CoV-2. SARS-CoV-2 is a single-stranded positive-sense RNA virus. Reverse transcription quantitative PCR (RT-qPCR) assays are the gold standard molecular test for detection of RNA viruses. The aim of this study was to construct an RNA-positive control based on MS2 phage-like particles (MS2 VLPs) to detect SARS-CoV-2 RNA. pCDFDuet-1 was used as a one-plasmid double-expression system to construct MS2 VLPs containing ssRNA of SARS-CoV-2. The sequence encoding one copy of maturase, His-tag and coat protein dimer was cloned and inserted into MCS1 of the plasmid; the fragment encoding protein N and ORF1ab from SARS-CoV-2 was cloned and inserted into MCS2. The prepared plasmid was transformed into Escherichia coli strain BL2 (DE3), and expression of the construct was induced by 1 mM isopropyl-L-thio-D-galactopyranoside (IPTG) at 30 degrees C for 12 hours. MS2 VLPs were purified and collected with Ni-NTA affinity chromatography columns. The size and shape of the MS2 VLPs were verified by transmission electron microscopy, and the stability of MS2 VLP packaged RNA was evaluated by treatment with RNase A. Effects of storage temperature and buffer on MS2 VLP stability were also investigated. The results showed that SARS-CoV-2 MS2 VLPs could be successfully produced by this one-plasmid double-expression system. MS2 VLPs showed high stability and may be used as a positive control in molecular diagnosis of COVID-19.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Tuning the tropism and infectivity of SARS-CoV-2 virus-like particles for mRNA delivery
    Yang, Qi
    Davidson, Bruce A.
    Pajic, Petar
    Chen, Xuyang
    Gokcumen, Omer
    Gao, Min
    Neelamegham, Sriram
    NUCLEIC ACIDS RESEARCH, 2025, 53 (05)
  • [22] ACE2-Decorated Virus-Like Particles Effectively Block SARS-CoV-2 Infection
    Bayraktar, Canan
    Kayabolen, Alisan
    Odabas, Arda
    Durgun, Aysegul
    Kok, Ipek
    Sevinc, Kenan
    Supramaniam, Aroon
    Idris, Adi
    Bagci-Onder, Tugba
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 6931 - 6943
  • [23] A new RNA vaccine platform based on MS2 virus-like particles produced in Saccharomyces cerevisiae
    Sun, Shipeng
    Li, Wenli
    Sun, Yu
    Pan, Yang
    Li, Jinming
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 407 (01) : 124 - 128
  • [24] Virus-like particles derived from bacteriophage MS2 as antigen scaffolds and RNA protective shells
    Naskalska, Antonina
    Heddle, Jonathan Gardiner
    NANOMEDICINE, 2024, 19 (12) : 1103 - 1115
  • [25] Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer
    Li, Jinming
    Sun, Yanli
    Jia, Tingting
    Zhang, Rui
    Zhang, Kuo
    Wang, Lunan
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (07) : 1683 - 1694
  • [26] Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells
    Kumar, Chandra Shekhar
    Singh, Balwant
    Rizvi, Zaigham Abbas
    Parray, Hilal Ahmad
    Verma, Jitender Kumar
    Ghosh, Sukanya
    Mukhopadhyay, Amitabha
    Awasthi, Amit
    Shrivastava, Tripti
    Banerjee, Manidipa
    ACS INFECTIOUS DISEASES, 2022, 8 (10): : 2119 - 2132
  • [27] A novel delivery platform based on Bacteriophage MS2 virus-like particles
    Fu, Yu
    Li, Jinming
    VIRUS RESEARCH, 2016, 211 : 9 - 16
  • [28] Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components
    Gashti, Anahita Bakhshizadeh
    Agbayani, Gerard
    Hrapovic, Sabahudin
    Nassoury, Nasha
    Coulombe, Nathalie
    Dudani, Renu
    Harrison, Blair A.
    Akache, Bassel
    Gilbert, Renald
    Chahal, Parminder Singh
    VACCINE, 2024, 42 (01) : 40 - 52
  • [29] Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles
    Elfayres, Ghada
    Paswan, Ricky Raj
    Sika, Laura
    Girard, Marie-Pierre
    Khalfi, Soumia
    Letanneur, Claire
    Milette, Keziah
    Singh, Amita
    Kobinger, Gary
    Berthoux, Lionel
    JOURNAL OF VIROLOGICAL METHODS, 2023, 322
  • [30] Kinetic Landscape of Single Virus-like Particles Highlights the Efficacy of SARS-CoV-2 Internalization
    Atemin, Aleksandar
    Ivanova, Aneliya
    Peppel, Wiley
    Stamatov, Rumen
    Gallegos, Rodrigo
    Durden, Haley
    Uzunova, Sonya
    Vershinin, Michael D.
    Saffarian, Saveez
    Stoynov, Stoyno S.
    VIRUSES-BASEL, 2024, 16 (08):